Mayne Pharma | MYX - Ebitda

Stock Price
2.32
Daily Change
-0.08 -3.33%
Monthly
-12.45%
Yearly
-67.87%
Q1 Forecast
2.33

Mayne Pharma reported AUD20.9M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Ansell USD 185.8M 7M Dec/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Cochlear AUD 306.4M 13.5M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Healius AUD 74.9M 40.3M Jun/2025
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Nanosonics AUD 12.49M 1.13M Dec/2025
Polynovo AUD 2.86M 1.12M Jun/2024
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025